Annals of Surgical Oncology

, Volume 18, Issue 4, pp 939–945 | Cite as

Local Control Following Single-Dose Intraoperative Radiotherapy Prior to Surgical Excision of Early-Stage Breast Cancer

  • Randall J. Kimple
  • Nancy Klauber-DeMore
  • Cherie M. Kuzmiak
  • Dag Pavic
  • Jun Lian
  • Chad A. Livasy
  • WingKeung M. Chiu
  • Dominic T. Moore
  • Carolyn I. Sartor
  • David W. Ollila
Breast Oncology



Multiple partial breast radiotherapy techniques are available. We have previously presented the technical details of our procedure of delivering partial breast irradiation with a single fraction of intraoperative radiotherapy (IORT) targeting the tumor in situ prior to partial mastectomy. This study details our completed, single-institution trial.

Materials and Methods

An IRB-approved, DSMB-monitored phase II trial was performed with the following inclusion criteria: women age ≥48, ultrasound-visible invasive ductal cancers <3 cm, clinically negative axillary nodes. IORT was delivered using mobile electron irradiator, at least a 1.5-cm radial and 1-cm deep margin; patients received 15 Gy and immediately underwent partial mastectomy. Ipsilateral breast recurrence was classified as true/marginal, elsewhere in the breast or nodal basin. Kaplan-Meier methods were used to estimate survival functions and exact 95% confidence intervals are reported.


Between 2003 and 2007, 71 women underwent IORT (median follow-up: 3.5 years). For patients with tumor-involved or close margins, additional therapy was required: 7 patients, total mastectomy; 11, whole breast radiation. Four women experienced invasive ipsilateral breast failures (1 new primary, 3 margin recurrences) for a 3-year local control rate of 49 of 53 (94.8%; 95% confidence interval 92.4% [95% CI] 84.2–98.3%), actuarial three-year in breast recurrence was 8% (95% CI 2–18%), and breast cancer-specific survival was 100%.


Intraoperative radiotherapy delivered to an in situ tumor is feasible, but our local control rate at 3.5 years is concerning. Possible changes to this technique to improve local control rates include better preoperative imaging (MRI), routine intraoperative ultrasound, and improved IORT delivery (larger cone, increased dose).


  1. 1.
    McGuire KP, Santillan AA, Kaur P, Meade T, Parbhoo J, Mathias M, et al. Are mastectomies on the rise? A 13-year trend analysis of the selection of mastectomy versus breast conservation therapy in 5865 patients. Ann Surg Oncol. 2009;16:2682–90.PubMedCrossRefGoogle Scholar
  2. 2.
    Katipamula R, Degnim AC, Hoskin T, Boughey JC, Loprinzi C, Grant CS, et al. Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging. J Clin Oncol. 2009;27:4082–8.PubMedCrossRefGoogle Scholar
  3. 3.
    Morrow M, White J, Moughan J, Owen J, Pajack T, Sylvester J, et al. Factors predicting the use of breast-conserving therapy in stage I and II breast carcinoma. J Clin Oncol. 2001;19:2254–62.PubMedGoogle Scholar
  4. 4.
    Nattinger AB, Hoffmann RG, Kneusel RT, Schapira MM. Relation between appropriateness of primary therapy for early-stage breast carcinoma and increased use of breast-conserving surgery. Lancet. 2000;356:1148–53.PubMedCrossRefGoogle Scholar
  5. 5.
    Hawley ST, Griggs JJ, Hamilton AS, Graff JJ, Janz NK, Morrow M, et al. Decision involvement and receipt of mastectomy among racially and ethnically diverse breast cancer patients. J Natl Cancer Inst. 2009;101:1337–47.PubMedCrossRefGoogle Scholar
  6. 6.
    McGinnis LS, Menck HR, Eyre HJ, Bland KI, Scott-Conner CE, Morrow M, et al. National Cancer Data Base survey of breast cancer management for patients from low income zip codes. Cancer. 2000;88:933–45.PubMedCrossRefGoogle Scholar
  7. 7.
    Mandelblatt JS, Hadley J, Kerner JF, Schulman KA, Gold K, Dunmore-Griffith J, et al. Patterns of breast carcinoma treatment in older women: patient preference and clinical and physical influences. Cancer. 2000;89:561–73.PubMedCrossRefGoogle Scholar
  8. 8.
    Nattinger AB, Kneusel RT, Hoffmann RG, Gilligan MA. Relationship of distance from a radiotherapy facility and initial breast cancer treatment. J Natl Cancer Inst. 2001;93:1344–6.PubMedCrossRefGoogle Scholar
  9. 9.
    Athas WF, Adams-Cameron M, Hunt WC, Amir-Fazli A, Key CR. Travel distance to radiation therapy and receipt of radiotherapy following breast-conserving surgery. J Natl Cancer Inst. 2000;92:269–71.PubMedCrossRefGoogle Scholar
  10. 10.
    Veronesi U, Marubini E, Mariani L, Galimberti V, Luini A, Veronesi P, et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol. 2001;12:997–1003.PubMedCrossRefGoogle Scholar
  11. 11.
    Sauer R, Sautter-Bihl M, Budach W, Feyer P, Harms W, Souchan R, et al. Accelerated partial breast irradiation. Cancer. 2007;110:1187–94.PubMedCrossRefGoogle Scholar
  12. 12.
    Sanders ME, Scroggins T, Ampil FL, Li BD. Accelerated partial breast irradiation in early-stage breast cancer. J Clin Oncol. 2007;25:996–1002.PubMedCrossRefGoogle Scholar
  13. 13.
    Veronesi U, Orecchia R, Luini A, Galimberti V, Gatti G, Intra M, et al. Full-dose intraoperative radiotherapy with electrons during breast-conserving surgery: experience with 590 cases. Ann Surg. 2005;242:101–6.PubMedCrossRefGoogle Scholar
  14. 14.
    Intra M, Gatti G, Luini A, Galimberti V, Veronesi P, Zurrida S, et al. Surgical technique of intraoperative radiotherapy in conservative treatment of limited-stage breast cancer. Arch Surg. 2002;137:737–40.PubMedCrossRefGoogle Scholar
  15. 15.
    Luini A, Orecchia R, Gatti G, Intra M, Ciocca M, Galimberti V, et al. The pilot trial on intraoperative radiotherapy with electrons (ELIOT): update on the results. Breast Cancer Res Treat. 2005;93:55–9.PubMedCrossRefGoogle Scholar
  16. 16.
    Kimple RJ, Klauber-DeMore N, Kuzmiak CM, Pavic D, Lian J, Livasy CA, et al. Cosmetic outcomes for accelerated partial breast irradiation prior to surgical excision of early stage breast cancer using single dose intraoperative radiotherapy. Int J Radiat Oncol Biol Phys. 2010 [Epub ahead of print].Google Scholar
  17. 17.
    Ollila DW, Klauber-DeMore N, Tesche LJ, Kuzmiak CM, Pavic D, Goyal LK, et al. Feasibility of breast preserving therapy with single fraction in situ radiotherapy delivered intraoperatively. Ann Surg Oncol. 2007;14:660–9.PubMedCrossRefGoogle Scholar
  18. 18.
    Holland R, Veling SH, Mravunac M, Hendriks JH. Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer. 1985;56:979–90.PubMedCrossRefGoogle Scholar
  19. 19.
    Liljegren G, Holmberg L, Bergh J, Lindgren A, Tabar L, Nordgren H, et al. 10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Clin Oncol. 1999;17:2326–33.PubMedGoogle Scholar
  20. 20.
    Vicini F, Arthur D, Polgar C, Kuske R. Defining the efficacy of accelerated partial breast irradiation: the importance of proper patient selection, optimal quality assurance, and common sense. Int J Radiat Oncol Biol Phys. 2003;57:1210–3.PubMedCrossRefGoogle Scholar
  21. 21.
    Smith TE, Lee D, Turner BC, Carter D, Haffty BG. True recurrence vs. new primary ipsilateral breast tumor relapse: an analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management. Int J Radiat Oncol Biol Phys. 2000;48:1281–9.PubMedCrossRefGoogle Scholar
  22. 22.
    Vaidya JS, Baum M, Tobias JS, D’Souza DP, Naidu SV, Morgan S, et al. Targeted intra-operative radiotherapy (Targit): an innovative method of treatment for early breast cancer. Ann Oncol. 2001;12:1075–80.PubMedCrossRefGoogle Scholar
  23. 23.
    Sacchini V, Beal K, Goldberg J, Montgomery L, Port E, McCormick B. Study of quadrant high-dose intraoperative radiation therapy for early-stage breast cancer. Br J Surg. 2008;95:1105–10.PubMedCrossRefGoogle Scholar
  24. 24.
    Wazer DE, Kaufman S, Cuttino L, DiPetrillo T, Arthur DW. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy. Int J Radiat Oncol Biol Phys. 2006;64:489–95.PubMedCrossRefGoogle Scholar
  25. 25.
    Li XA, Tai A, Arthur DW, Buchholz TA, Macdonald S, Marks LB, et al. Variability of target and normal structure delineation for breast cancer radiotherapy: an RTOG Multi-Institutional and Multiobserver Study. Int J Radiat Oncol Biol Phys. 2009;73:944–51.PubMedCrossRefGoogle Scholar
  26. 26.
    Sanghani M, Wazer DE. Patient selection for NSABP B-39/RTOG 0413: have we posed the right questions in the right way? Brachytherapy. 2007;6:119–22.PubMedCrossRefGoogle Scholar
  27. 27.
    Holmes DR, Baum M, Joseph D. The TARGIT trial: targeted intraoperative radiation therapy versus conventional postoperative whole-breast radiotherapy after breast-conserving surgery for the management of early-stage invasive breast cancer (a trial update). Am J Surg. 2007;194:507–10.PubMedCrossRefGoogle Scholar
  28. 28.
    Vaidya JS, Baum M, Tobias JS, Massarut S, Wenz F, Murphy O, et al. Targeted intraoperative radiotherapy (TARGIT) yields very low recurrence rates when given as a boost. Int J Radiat Oncol Biol Phys. 2006;66:1335–8.PubMedCrossRefGoogle Scholar
  29. 29.
    Reitsamer R, Peintinger F, Kopp M, Menzel C, Kogelnik HD, Sedlmayer F. Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. A sequential intervention study. Strahlenther Onkol. 2004;180:38–44.PubMedCrossRefGoogle Scholar
  30. 30.
    Kraus-Tiefenbacher U, Bauer L, Scheda A, Fleckenstein K, Keller A, Herskind C, et al. Long-term toxicity of an intraoperative radiotherapy boost using low energy X-rays during breast-conserving surgery. Int J Radiat Oncol Biol Phys. 2006;66:377–81.PubMedCrossRefGoogle Scholar
  31. 31.
    Belletti B, Vaidya JS, D’Andrea S, Entschladen F, Roncadin M, Lovat F, et al. Targeted intraoperative radiotherapy impairs the stimulation of breast cancer cell proliferation and invasion caused by surgical wounding. Clin Cancer Res. 2008;14:1325–32.PubMedCrossRefGoogle Scholar
  32. 32.
    Story M, Kodym R, Saha D. Exploring the possibility of unique molecular, biological, and tissue effects with hypofractionated radiotherapy. Semin Radiat Oncol. 2008;18:244–8.PubMedCrossRefGoogle Scholar
  33. 33.
    Plataniotis GA, Dale RG. Biologically effective dose–response relationship for breast cancer treated by conservative surgery and postoperative radiotherapy. Int J Radiat Oncol Biol Phys. 2009;75:512–7.PubMedCrossRefGoogle Scholar
  34. 34.
    Williams MV, Denekamp J, Fowler JF. A review of alpha/beta ratios for experimental tumors: implications for clinical studies of altered fractionation. Int J Radiat Oncol Biol Phys. 1985;11:87–96.PubMedCrossRefGoogle Scholar
  35. 35.
    Smith BD, Arthur DW, Buchholz TA, Haffty BG, Hahn CA, Hardenbergh PH, et al. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). J Am Coll Surg. 2009;209:269–77.PubMedCrossRefGoogle Scholar
  36. 36.
    Tendulkar RD, Chellman-Jeffers M, Rybicki LA, Rim A, Kotwal A, Macklis R, et al. Preoperative breast magnetic resonance imaging in early breast cancer: implications for partial breast irradiation. Cancer. 2009;115:1621–30.PubMedCrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2010

Authors and Affiliations

  • Randall J. Kimple
    • 1
  • Nancy Klauber-DeMore
    • 2
    • 5
  • Cherie M. Kuzmiak
    • 3
    • 5
  • Dag Pavic
    • 3
    • 5
  • Jun Lian
    • 1
  • Chad A. Livasy
    • 4
    • 5
  • WingKeung M. Chiu
    • 5
  • Dominic T. Moore
    • 5
  • Carolyn I. Sartor
    • 1
    • 5
  • David W. Ollila
    • 2
    • 5
  1. 1.Department of Radiation OncologyUniversity of North Carolina at Chapel HillChapel HillUSA
  2. 2.Department of SurgeryUniversity of North Carolina at Chapel HillChapel HillUSA
  3. 3.Department of RadiologyUniversity of North Carolina at Chapel HillChapel HillUSA
  4. 4.Department of PathologyUniversity of North Carolina at Chapel HillChapel HillUSA
  5. 5.Lineberger Comprehensive Cancer CenterUniversity of North Carolina at Chapel HillChapel HillUSA

Personalised recommendations